Company / Capital Returned to Shareholders per Share
Pacira BioSciences, Inc. Capital Returned to Shareholders per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$3.21
FY2025
5-year range
$0.00 / $3.21
FY2022-FY2025
Trend
+493.4%
vs FY2024
Sector context
#10 of 51
Health Care
What the data says
Pacira BioSciences, Inc.'s capital returned to shareholders per share of $3.21 is higher than 80% of companies in the Health Care sector (FY2025). Improved from $0.00 to $3.21 over the past 2 years.
Based on SEC 10-K filings.
3.21 in FY2025. Top quartile in the Health Care sector.
Improved from $0.00 to $3.21 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+17.3% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 493.4% year-over-year.
- Ranks #10 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.21 | +493.4% |
| FY2024 | $0.54 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026